About · by Bajpai Labs

Target discovery built for portfolio gates, not gene lists.

TargetIQ is Bajpai Labs' disease target discovery engine: a multi-omics AI platform that ranks druggable targets with full evidence dossiers before any chemistry or screening begins.

Our aim

Get teams to the right target decision faster.

TargetIQ exists because most discovery programs waste capital pursuing targets without concordant genetic evidence, druggability assessment, or competitive context. We replace internal gene lists with ranked, gate-ready dossiers.

01
Rank before chemistry

Surface the 8 to 15 targets worth investing in, not hundreds of undifferentiated GWAS hits. Every engagement is scoped to a portfolio decision.

02
Evidence dossiers, not dashboards

From multi-omics integration through druggability scoring and competitive landscape: one ranked deliverable with gate-ready documentation.

03
Portfolio gate timelines

Typical engagements deliver in 2–4 weeks with full evidence dossiers. Built for teams that cannot wait six months for internal bioinformatics.

04
Knowledge-graph depth

GNNs over curated biological networks surface targets missed by single-source GWAS or expression analysis alone.

Mission

Bridge multi-omics intelligence and portfolio decisions.

“Enable discovery teams to commit chemistry budget only to targets that multi-omics evidence, druggability scoring, and competitive analysis say are worth the investment.”
What we believe

The principles behind every target ranking.

  • Concordance over single-source

    A target supported by GWAS, expression, and pathway evidence beats a lone GWAS hit every time.

  • Gate-ready accountability

    Evidence dossiers with decision frameworks. Not spreadsheet exports.

  • Multi-omics + GNN methods

    Knowledge-graph neural networks composed with published genetic and pathway techniques from Bajpai Labs.

  • Senior-led engagement

    Direct access to the architects who designed the engine, from scoping through dossier delivery.

Part of Bajpai Labs

Early-stage intelligence for drug discovery.

TargetIQ is Bajpai Labs' target discovery platform—upstream of chemistry engines like HelixForge and GeneForge. The same research depth and production accountability that drives the parent lab drives every TargetIQ engagement.